Exchange
GPW
Every company in the roster listed on GPW.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Celon PharmaCLN · GPW | 2 assets: 2 Ph 2 | CPL500036Phase 2 · Parkinson's DiseaseReliable signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).